Prostate cancer Board decisions

The Board denied the Veteran's claims for service connection for prostate cancer, urinary incontinence, and erectile dysfunction. The Board found that there was no evidence to support a finding of direct service connection or secondary service connection due to his currently non-service-connected prostate cancer.

The Board has remanded the case due to the need for additional development regarding whether the U.S.S. Frank E. Evans engaged shore targets in Vietnam during the Veteran's service.

The Veteran's initial claim for a higher rating for prostate cancer residuals was denied. A 20 percent rating is granted beginning July 20, 2018. The issue of entitlement to an initial compensable rating for erectile dysfunction is remanded.

The Veteran's claims for service connection for coronary artery disease and prostate cancer are remanded due to the need to verify his exposure to toxic chemicals during service.

The Board has dismissed the claims of service connection for diabetes, arthritis, and prostate cancer as there is no timely Notice of Disagreement filed within one year from the November 2018 rating decision.

The Veteran's diabetes mellitus, type II and prostate cancer are presumed related to exposure to herbicide agents while in service. The heart disorder is remanded for further examination.

The Board has determined that the Veteran's hypertension is related to service, specifically exposure to contaminated water at Camp Lejeune. The Veteran will need to undergo a VA examination to determine if his hypertension was caused or aggravated by his service-connected disabilities.

The Veteran's prostate cancer residuals resulted in increased urinary frequency, but did not meet the criteria for higher initial disability ratings due to lack of renal dysfunction or other specific symptoms.

The Veteran's prostate cancer residuals are being remanded for further evaluation due to the need for additional private medical records and a VA examination.

The Veteran's claims for service connection for prostate cancer and an initial disability rating for bilateral hearing loss, as well as a prior effective date for the grant of service connection for bilateral hearing loss, have all been denied by the Board.

The Board denied the Veteran's claim for compensation under 38 U.S.C. § 1151 as there was no evidence that VA care caused his cancer or prostate cancer.

The Board has remanded the case due to a need for updated medical records and a VA audiology examination. The service connection for prostate cancer is stayed until further notice.

The Veteran's claim for service connection for prostate cancer is being remanded due to new evidence received since the previous denial. The Board finds that there is a reasonable possibility of establishing a nexus between his prostate cancer and his period of service.

The Board has granted service connection for prostate cancer and the cause of death due to prostate cancer, attributing these findings to exposure to contaminated water at Camp Lejeune during military service.

The Board has granted service connection for bilateral hearing loss. The issues of service connection for a heart condition, prostate cancer, and skin cancer are remanded due to the need for additional development.

The Veteran's claims for service connection for a pulmonary disability, multi-joint aches and pains, and prostate cancer are being remanded due to the need for additional medical examinations and opinions.

The Veteran's erectile dysfunction is granted as secondary to his service-connected prostate cancer. The Veteran also receives special monthly compensation for the loss of use of a creative organ.

The Board has granted service connection for the Veteran's cause of death due to exposure to herbicide agents during his service at Royal Thai Air Force Base Nahkhon Phanom, finding that prostate cancer was a contributory cause of his death.

The Veteran's claim for a compensable evaluation for erectile dysfunction has been denied. The Board has also remanded the issue of his prostate cancer, as there are outstanding private treatment records that need to be obtained.

The Board has remanded the issues of entitlement to extraschedular ratings for chronic pelvic pain, prostate cancer residuals, prostatectomy scar, and erectile dysfunction due to unresolved development needs.